Literature DB >> 15270775

AP-2 transcription factor family member expression, activity, and regulation in human epidermal keratinocytes in vitro.

Claudia Popa1, Alison L Dahler, Magdalena M Serewko-Auret, Chung F Wong, Louise Smith, Liam M Barnes, Geoff M Strutton, Nicholas A Saunders.   

Abstract

The AP-2 transcription factor family is presumed to play an important role in the regulation of the keratinocyte squamous differentiation program; however, limited functional data are available to support this. In the present study, the activity and regulation of AP-2 were examined in differentiating human epidermal keratinocytes. We report that (1) AP-2 transcriptional activity decreases in differentiated keratinocytes but remains unchanged in differentiation-insensitive squamous cell carcinoma cell lines, (2) diminished AP-2 transcriptional activity is associated with a loss of specific DNA-bound AP-2 complexes, and (3) there is an increase in the ability of cytoplasmic extracts, derived from differentiated keratinocytes, to phosphorylate AP-2 alpha and AP-2 beta when cells differentiate. In contrast, extracts from differentiation-insensitive squamous cell carcinoma cells are unable to phosphorylate AP-2 proteins. Finally, the phosphorylation of recombinant AP-2 alpha by cytosolic extracts from differentiated keratinocytes is associated with decreased AP-2 DNA-binding activity. Combined, these data indicate that AP-2 trans-activation and DNA-binding activity decrease as keratinocytes differentiate, and that this decreased activity is associated with an enhanced ability to phosphorylate AP-2 alpha and beta.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15270775     DOI: 10.1111/j.1432-0436.2004.07205001.x

Source DB:  PubMed          Journal:  Differentiation        ISSN: 0301-4681            Impact factor:   3.880


  1 in total

1.  AP-2 participates in the transcriptional control of the amyloid precursor protein (APP) gene in oral squamous cell carcinoma.

Authors:  Matthew J Provenzano; Lei Yu; Michael J Hitchler; Matthew P Fitzgerald; Robert A Robinson; Sigrid Wayne; Mark Ver Meer; Frederick E Domann
Journal:  Exp Mol Pathol       Date:  2007-06-26       Impact factor: 3.362

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.